LINCS MCF 10A Common Project: Rolling-time-point sensitivity measures of the MCF 10A breast cell line to 8 small molecule perturbagens. Dataset 3 of 15: End-point cell counts and normalized growth rate inhibition values for all technical replicates of biological replicate 3. - Dataset (ID:20311)
Download: Excel (XLSX), Comma-separated (CSV)
| Cell | Small Molecule | Small Mol Concentration (uM) | Time Point (hr) | Total Cell Count Before Treatment | Total Cell Count After Treatment | Total Control Cell Count | Relative Cell Count | Normalized Growth Rate Inhibition Value | Assay Plate | Assay Well |
|---|---|---|---|---|---|---|---|---|---|---|
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 14.58 | 84.90 | 34 | 663 | 0.0513 | -0.2655 | MN20160318_Q02 | N18 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 14.58 | 84.90 | 1013 | 663 | 1.5270 | 1.3068 | MN20160318_Q02 | N18 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 16.29 | 84.90 | 462 | 766 | 0.6025 | 0.7050 | MN20160318_Q02 | J03 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 16.29 | 84.90 | 1043 | 766 | 1.3601 | 1.2034 | MN20160318_Q02 | J03 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 16.29 | 84.90 | 44 | 766 | 0.0574 | -0.1870 | MN20160318_Q02 | N18 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 16.29 | 84.90 | 1031 | 766 | 1.3444 | 1.1954 | MN20160318_Q02 | N18 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 17.99 | 84.90 | 594 | 898 | 0.6608 | 0.7708 | MN20160318_Q02 | J03 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 17.99 | 84.90 | 1085 | 898 | 1.2069 | 1.1136 | MN20160318_Q02 | J03 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 17.99 | 84.90 | 53 | 898 | 0.0590 | -0.1292 | MN20160318_Q02 | N18 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 17.99 | 84.90 | 1036 | 898 | 1.1524 | 1.0851 | MN20160318_Q02 | N18 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 19.69 | 84.90 | 914 | 1239 | 0.7374 | 0.8486 | MN20160318_Q02 | J03 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 19.69 | 84.90 | 1082 | 1239 | 0.8730 | 0.9310 | MN20160318_Q02 | J03 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 19.69 | 84.90 | 49 | 1239 | 0.0395 | -0.1325 | MN20160318_Q02 | N18 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 19.69 | 84.90 | 1026 | 1239 | 0.8278 | 0.9046 | MN20160318_Q02 | N18 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 21.40 | 84.90 | 1028 | 1454 | 0.7067 | 0.8376 | MN20160318_Q02 | J03 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 21.40 | 84.90 | 1102 | 1454 | 0.7576 | 0.8690 | MN20160318_Q02 | J03 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 21.40 | 84.90 | 60 | 1454 | 0.0412 | -0.0812 | MN20160318_Q02 | N18 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 21.40 | 84.90 | 1049 | 1454 | 0.7211 | 0.8467 | MN20160318_Q02 | N18 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 23.10 | 84.90 | 1047 | 1616 | 0.6478 | 0.8058 | MN20160318_Q02 | J03 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 23.10 | 84.90 | 1096 | 1616 | 0.6781 | 0.8254 | MN20160318_Q02 | J03 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 23.10 | 84.90 | 67 | 1616 | 0.0415 | -0.0542 | MN20160318_Q02 | N18 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 23.10 | 84.90 | 1035 | 1616 | 0.6404 | 0.8009 | MN20160318_Q02 | N18 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 24.81 | 84.90 | 1070 | 1769 | 0.6047 | 0.7831 | MN20160318_Q02 | J03 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 24.81 | 84.90 | 1090 | 1769 | 0.6160 | 0.7906 | MN20160318_Q02 | J03 |
| MCF 10A-H2B-mCherry | Palbociclib | 3.1623 | 24.81 | 84.90 | 60 | 1769 | 0.0339 | -0.0762 | MN20160318_Q02 | N18 |